Related Experiment Video
Updated: Jul 17, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Association between GLP-1-based therapy and small-bowel transit time during capsule endoscopy: a prospective,
Fadi Abu Baker1,2, Melhem Melhem3, Osnat Kalnizki4
1Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel.
Glucagon-like peptide-1 (GLP-1) based therapies are linked to longer small-bowel transit times in capsule endoscopy. Routine discontinuation is not advised, but individual patient assessment is recommended.
Area of Science:
- Gastroenterology
- Endocrinology
- Pharmacology
Background:
- Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used for type 2 diabetes and obesity.
- The effect of GLP-1 based therapies on gastrointestinal transit, particularly small-bowel transit time during capsule endoscopy, is not well established.
- Understanding these effects is crucial for optimizing capsule endoscopy procedures and interpreting findings in patients on these medications.
Purpose of the Study:
- To evaluate the association between glucagon-like peptide-1 (GLP-1) based therapy and small-bowel transit time (SBTT) during capsule endoscopy.
- To compare SBTT, gastric transit time (GTT), capsule completion, and endoscopic findings between patients on GLP-1 based therapy and controls.
Main Methods:
- A prospective, multicentre, observational study involving adults undergoing small-bowel capsule endoscopy.
- Patients receiving GLP-1 based therapy (GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists) were compared with non-exposed controls.
- Primary outcome was SBTT; secondary outcomes included GTT, capsule completion, and endoscopic findings.
Main Results:
- Patients on GLP-1 based therapy (n=34) exhibited significantly longer SBTT compared to controls (n=95) (median 311.0 vs 236.0 min; p<0.001).
- GLP-1 based therapy was independently associated with longer SBTT in multivariable analysis (adjusted β+83 min; p=0.042), after adjusting for age, BMI, diabetes, and indication.
- No significant differences were observed in GTT, capsule completion rates, or clinically significant endoscopic findings between the groups.
Conclusions:
- GLP-1 based therapy is associated with prolonged small-bowel transit time during capsule endoscopy.
- Current findings do not support the routine discontinuation of GLP-1 based therapy before capsule endoscopy.
- Individualized patient assessment and larger studies are warranted to further evaluate capsule completion and repeat examination rates.
Related Concept Videos
Endoscopic Procedures III: Video Capsule Endoscopy
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Gastric Emptying
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Endoscopic Procedures V: ERCP
Patient...
